These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27285322)

  • 1. Revisiting the role of erythropoietin for treatment of ocular disorders.
    Shirley Ding SL; Leow SN; Munisvaradass R; Koh EH; Bastion ML; Then KY; Kumar S; Mok PL
    Eye (Lond); 2016 Oct; 30(10):1293-1309. PubMed ID: 27285322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of erythropoietin in ophthalmology: a review.
    Feizi S; Alemzadeh-Ansari M; Karimian F; Esfandiari H
    Surv Ophthalmol; 2022; 67(2):427-439. PubMed ID: 34157346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin in diabetic retinopathy.
    Reid G; Lois N
    Vision Res; 2017 Oct; 139():237-242. PubMed ID: 28652140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Latest Evidence of Erythropoietin in the Treatment of Glaucoma.
    Lin TY; Lai YF; Chen YH; Lu DW
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy.
    Hernández C; Simó R
    Endocrine; 2012 Apr; 41(2):220-6. PubMed ID: 22167324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.
    Mitsuhashi J; Morikawa S; Shimizu K; Ezaki T; Yasuda Y; Hori S
    Exp Eye Res; 2013 Jan; 106():64-73. PubMed ID: 23178551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin and retinopathy of prematurity.
    Romagnoli C; Tesfagabir MG; Giannantonio C; Papacci P
    Early Hum Dev; 2011 Mar; 87 Suppl 1():S39-42. PubMed ID: 21303729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin and the nervous system.
    Genc S; Koroglu TF; Genc K
    Brain Res; 2004 Mar; 1000(1-2):19-31. PubMed ID: 15053948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin: a hormone with multiple functions.
    Lombardero M; Kovacs K; Scheithauer BW
    Pathobiology; 2011; 78(1):41-53. PubMed ID: 21474975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy.
    Chen J; Connor KM; Aderman CM; Willett KL; Aspegren OP; Smith LE
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1329-35. PubMed ID: 18952918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Physiology of eryhtropoietin and its therapeutic use].
    Casadevall N
    Ann Pharm Fr; 1996; 54(4):151-6. PubMed ID: 8881101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin protects retinal pigment epithelial cells against the increase of permeability induced by diabetic conditions: essential role of JAK2/ PI3K signaling.
    Garcia-Ramírez M; Hernández C; Ruiz-Meana M; Villarroel M; Corraliza L; García-Dorado D; Simó R
    Cell Signal; 2011 Oct; 23(10):1596-602. PubMed ID: 21620963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy].
    Watanabe D
    Nippon Ganka Gakkai Zasshi; 2007 Nov; 111(11):892-8. PubMed ID: 18051819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel role of erythropoietin in proliferative diabetic retinopathy.
    Takagi H; Watanabe D; Suzuma K; Kurimoto M; Suzuma I; Ohashi H; Ojima T; Murakami T
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S62-4. PubMed ID: 17481772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies.
    Maiese K; Chong ZZ; Li F; Shang YC
    Prog Neurobiol; 2008 Jun; 85(2):194-213. PubMed ID: 18396368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erythropoietin: a new perspective in cardiovascular therapy].
    Raddino R; Robba D; Caretta G; Bonadei I; Teli M; Zanini G; Madureri A; Vizzardi E; Dei Cas L
    Monaldi Arch Chest Dis; 2008 Dec; 70(4):206-13. PubMed ID: 19263796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role and therapeutic potential of melatonin in age-related ocular diseases.
    Crooke A; Huete-Toral F; Colligris B; Pintor J
    J Pineal Res; 2017 Sep; 63(2):. PubMed ID: 28658514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New avenues of exploration for erythropoietin.
    Maiese K; Li F; Chong ZZ
    JAMA; 2005 Jan; 293(1):90-5. PubMed ID: 15632341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2.
    Kilic U; Kilic E; Soliz J; Bassetti CI; Gassmann M; Hermann DM
    FASEB J; 2005 Feb; 19(2):249-51. PubMed ID: 15556972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erythropoietin--physiology and therapeutic potentialities].
    Möllmann M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1992 Dec; 27(8):461-8. PubMed ID: 1489869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.